TrialDiabetes, obesity & metabolism2019

Renal effects of a sodium-glucose cotransporter 2 inhibitor, tofogliflozin, in relation to sodium intake and glycaemic status.

Kiyohide Nunoi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.